A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

February 8, 2024

Study Completion Date

February 28, 2024

Conditions

Healthy Subjects

Interventions

DRUG

AP301

Orally administered

Trial Locations (1)

Nucleus Network Pty Ltd, Melbourne

All Listed Sponsors

lead

Alebund Pty Ltd

INDUSTRY

NCT06100627 - A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers | Biotech Hunter | Biotech Hunter